Filter
2606
Filtered Results: 2606
Text search:
prophylaxis
Featured
Recommendations
263
New Publications
722
Language
Document type
No document type
1578
Guidelines
470
Studies & Reports
259
Manuals
110
Strategic & Response Plan
60
Fact sheets
50
Training Material
35
Infographics
17
Situation Updates
12
Brochures
6
Resource Platforms
6
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
138
Kenya
84
South Africa
78
Global
61
Tanzania
55
Ethiopia
54
Malawi
48
Rwanda
45
Zambia
45
Uganda
43
Namibia
43
Germany
42
Nigeria
39
Nepal
38
Congo, Democratic Republic of
34
Senegal
32
Liberia
32
Africa
31
Western and Central Europe
31
Sierra Leone
27
Lesotho
26
Ghana
23
Latin America and the Carribbean
23
Zimbabwe
22
Asia
19
Burkina Faso
18
Madagascar
18
Ukraine
17
Botswana
17
Haiti
16
Bangladesh
16
Benin
15
Cameroon
15
Philippines
15
Russia
15
Cambodia
13
Myanmar / Burma
13
Mozambique
11
Eastern Europe
11
Brazil
9
Central African Republic
9
Syria
8
Guinea
8
East and Southern Africa
8
Indonesia
8
Eswatini/ Swaziland
8
South–East Asia Region
7
Pakistan
6
West and Central Africa
5
Sri Lanka
5
Georgia
5
North Macedonia
4
Peru
4
Paraguay
4
Argentina
4
South Sudan
4
Togo
3
Armenia
3
Middle East and North Africa
3
Western Pacific Region
3
France
3
Vietnam
3
Angola
3
Thailand
2
Albania
2
Laos
2
Niger
2
Afghanistan
2
USA
2
Guinea-Bissau
2
Eastern Europe and Central Asia
2
Belgium
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Yemen
2
Mali
2
Bhutan
2
Tajikistan
1
Switzerland
1
Colombia
1
Gambia
1
Canada
1
Fiji
1
Burundi
1
Malaysia
1
Austria
1
Qatar
1
Bulgaria
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Denmark
1
Portugal
1
Belarus
1
Southern Africa
1
Bolivia
1
Lebanon
1
Moldova
1
Egypt
1
Romania
1
Chad
1
Libya
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1029
Clinical Guidelines
286
Women & Child Health
158
Key Resources
86
Public Health
73
Capacity Building
51
Pharmacy & Technologies
19
Toolboxes
HIV
574
TB
140
COVID-19
113
AMR
109
Rapid Response
93
Caregiver
74
Pharmacy
73
NTDs
61
Ebola & Marburg
56
Mental Health
48
Refugee
47
Malaria
43
Conflict
38
Specific Hazards
20
Planetary Health
17
Polio
17
Global Health Education
13
Health Financing Toolbox
11
Zika
10
Disability
9
NCDs
8
Natural Hazards
7
Cholera
5
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEP
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex C
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Rabies is a public health problem in Asia and vaccine affordability is an issue.
There is no reduction in the number of persons seeking post-exposure prophylaxis.
The high cost of cell culture vaccines for intramuscular use is a limiting factor.
Intradermal rabies vaccination offers cost-effectiv...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
